New Compounds Seen to Kill Lymphoma/Leukemia Cells via Tumor Suppressor Pathway

New Compounds Seen to Kill Lymphoma/Leukemia Cells via Tumor Suppressor Pathway

Activation of the p53 tumor suppressor pathway has been pursued as an anticancer strategy in research and the clinic for many years, due to p53's ability to suppress cancer growth or terminate cancer cell proliferation in vivo. This type of therapy is

(Visited 15 times, 1 visits today)
6
Like
Save

Comments

Comments are disabled for this post.